Literature DB >> 25023820

Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension.

Zeenat Safdar1, Emilio Tamez2, Wenyaw Chan3, Basant Arya4, Yimin Ge5, Anita Deswal4, Biykem Bozkurt4, Adaani Frost2, Mark Entman4.   

Abstract

OBJECTIVES: The goal of this study was to determine if biomarkers of collagen metabolism in PAH identify patients with worse disease and higher risk of death.
BACKGROUND: The relationship between circulating markers of collagen metabolism, degree of disease severity, and outcome in pulmonary arterial hypertension (PAH) is unknown.
METHODS: Patients with stable idiopathic, anorexigen-associated, and hereditary PAH were prospectively enrolled. Levels of the following collagen biomarkers were measured: N-terminal pro-peptide of type III procollagen (PIIINP), C-terminal telopeptide of collagen type I (CITP), matrix metalloproteinase (MMP)-9, and tissue inhibitor of metalloproteinase (TIMP)-1. Patients were divided into mild, moderate, and severe PAH groups. Data were compared between tertiles of each biomarker. Pearson correlation and Spearman rank coefficient analyses were performed. Data on time to death or transplantation were examined by Kaplan-Meier survival curves.
RESULTS: Circulating levels of PIIINP, CITP, MMP-9, and TIMP-1 were higher in the PAH group (n = 68) as compared with age- and sex-matched healthy controls (n = 37) (p < 0.001 for each). PIIINP levels increased with the severity of disease (p = 0.002). PIIINP tertile data indicated that with increasing levels, 6-min walk distance and cardiac index decreased, World Health Organization functional classification worsened, and resting heart rate increased. A significant correlation existed between PIIINP levels and worsening World Health Organization functional classification (rs = 0.320; p < 0.01), and there was a negative correlation between cardiac index and 6-min walk distance (r = -0.304 and r = -0.362, respectively; p < 0.05). PIIINP tertiles showed a trend toward worse outcome in patients with higher tertiles (lung transplant or death) (p = 0.07; log-rank test).
CONCLUSIONS: Markers of collagen metabolism were associated with worse disease in patients with PAH.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BNP; PIIINP; heart failure; vascular remodeling

Mesh:

Substances:

Year:  2014        PMID: 25023820      PMCID: PMC4180669          DOI: 10.1016/j.jchf.2014.03.013

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  44 in total

1.  Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis.

Authors:  R B Low; M S Giancola; T E King; J Chapitis; P Vacek; G S Davis
Journal:  Am Rev Respir Dis       Date:  1992-09

2.  Collagen and elastin metabolism in hypertensive pulmonary arteries of rats.

Authors:  G J Poiani; C A Tozzi; S E Yohn; R A Pierce; S A Belsky; R A Berg; S Y Yu; S B Deak; D J Riley
Journal:  Circ Res       Date:  1990-04       Impact factor: 17.367

3.  Changes in the composition and metabolism of arterial collagens during the development of pulmonary hypertension in rabbits.

Authors:  J E Bishop; D Guerreiro; G J Laurent
Journal:  Am Rev Respir Dis       Date:  1990-02

4.  Serum type III procollagen peptide in patients with Pneumocystis carinii infection. The Copenhagen-Amsterdam PCP-Prednisolone Study Group.

Authors:  K D Bentsen; T L Nielsen; J K Eaftinck Schattenkerk; B N Jensen; J D Lundgren
Journal:  Am Rev Respir Dis       Date:  1993-12

5.  Active collagen synthesis by pulmonary arteries in human primary pulmonary hypertension.

Authors:  M D Botney; M J Liptay; L R Kaiser; J D Cooper; W C Parks; R P Mecham
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

6.  Transpulmonary gradient of type III procollagen peptides: acute effects of cardio-pulmonary bypass.

Authors:  N K Harrison; G J Laurent; T W Evans
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

7.  Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries.

Authors:  M D Botney; L R Kaiser; J D Cooper; R P Mecham; D Parghi; J Roby; W C Parks
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

8.  Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.

Authors:  M Yoshimura; H Yasue; K Okumura; H Ogawa; M Jougasaki; M Mukoyama; K Nakao; H Imura
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

9.  Serum procollagen III peptide levels in subjects with sarcoidosis. A 5-year follow-up study.

Authors:  W R Pohl; A B Thompson; H Köhn; S Losch; H Umek; E Legenstein; F Kummer; S I Rennard; H Klech
Journal:  Am Rev Respir Dis       Date:  1992-02

10.  Cardiac collagen changes during the development of right ventricular hypertrophy in tight-skin mice with emphysema.

Authors:  C Gardi; P A Martorana; P Calzoni; E Cavarra; P Marcolongo; M M de Santi; P van Even; G Lungarella
Journal:  Exp Mol Pathol       Date:  1994-04       Impact factor: 3.362

View more
  32 in total

1.  Collagen biomarkers and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Purnema Madahar; Daniel A Duprez; Anna J Podolanczuk; Elana J Bernstein; Steven M Kawut; Ganesh Raghu; R Graham Barr; Myron D Gross; David R Jacobs; David J Lederer
Journal:  Respir Med       Date:  2018-06-06       Impact factor: 3.415

2.  Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension.

Authors:  Brett E Fenster; Luis Lasalvia; Joyce D Schroeder; Jamey Smyser; Lori J Silveira; J Kern Buckner; Kevin K Brown
Journal:  Heart Vessels       Date:  2015-05-15       Impact factor: 2.037

Review 3.  Update in Pulmonary Vascular Disease 2015.

Authors:  Bradley A Maron; Mark T Gladwin; Marc A Simon
Journal:  Am J Respir Crit Care Med       Date:  2016-06-15       Impact factor: 21.405

Review 4.  Update on novel targets and potential treatment avenues in pulmonary hypertension.

Authors:  John C Huetsch; Karthik Suresh; Meghan Bernier; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-02       Impact factor: 5.464

Review 5.  Microvessel mechanobiology in pulmonary arterial hypertension: cause and effect.

Authors:  Nathaniel C Bloodworth; James D West; W David Merryman
Journal:  Hypertension       Date:  2014-12-22       Impact factor: 10.190

6.  Compartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patients.

Authors:  Julia Hoffmann; Leigh M Marsh; Mario Pieper; Elvira Stacher; Bahil Ghanim; Gabor Kovacs; Peter König; Heinrike Wilkens; Hans Michael Haitchi; Gerald Hoefler; Walter Klepetko; Horst Olschewski; Andrea Olschewski; Grazyna Kwapiszewska
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-04-03       Impact factor: 5.464

7.  Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial Hypertension.

Authors:  Veronika Wetzl; Svenja Lena Tiede; Lothar Faerber; Norbert Weissmann; Ralph Theo Schermuly; Hossein Ardeschir Ghofrani; Henning Gall
Journal:  Lung       Date:  2017-05-17       Impact factor: 2.584

8.  Collagen Metabolism Biomarkers and Health Related Quality of Life in Pulmonary Arterial Hypertension.

Authors:  Zeenat Safdar; Emilio Tamez; Adaani Frost; Danielle Guffey; Charles G Minard; Mark L Entman
Journal:  Int J Cardiovasc Res       Date:  2015

9.  Proteomic profiling identifies key differences between inter-stage infants with single ventricle heart disease and healthy controls.

Authors:  Benjamin S Frank; Ludmila Khailova; Lori Silveira; Max B Mitchell; Gareth J Morgan; Elena W Y Hsieh; Michael V DiMaria; Mark Twite; Jelena Klawitter; Jesse A Davidson
Journal:  Transl Res       Date:  2020-10-09       Impact factor: 7.012

10.  Extracellular matrix collagen biomarkers levels in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Wenyi Pang; Zhu Zhang; Yunxia Zhang; Meng Zhang; Ran Miao; Yuanhua Yang; Wanmu Xie; Jun Wan; Zhenguo Zhai; Chen Wang
Journal:  J Thromb Thrombolysis       Date:  2020-11-11       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.